# Trial of Curcumin in Cutaneous T-cell Lymphoma Patients

> **NCT00969085** · PHASE2 · WITHDRAWN · sponsor: **M.D. Anderson Cancer Center**

## Conditions studied

- Cutaneous T-cell Lymphoma

## Interventions

- **DRUG:** Curcumin (Turmeric)
- **BEHAVIORAL:** Questionnaires
- **OTHER:** Photos

## Key facts

- **NCT ID:** NCT00969085
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2012-11
- **Primary completion:** 2014-11
- **Final completion:** —
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2012-09-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00969085

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00969085, "Trial of Curcumin in Cutaneous T-cell Lymphoma Patients". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00969085. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*